These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


296 related items for PubMed ID: 28256089

  • 1. Striatal activation by optogenetics induces dyskinesias in the 6-hydroxydopamine rat model of Parkinson disease.
    F Hernández L, Castela I, Ruiz-DeDiego I, Obeso JA, Moratalla R.
    Mov Disord; 2017 Apr; 32(4):530-537. PubMed ID: 28256089
    [Abstract] [Full Text] [Related]

  • 2. Striatal D1 medium spiny neuron activation induces dyskinesias in parkinsonian mice.
    Perez XA, Zhang D, Bordia T, Quik M.
    Mov Disord; 2017 Apr; 32(4):538-548. PubMed ID: 28256010
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease.
    Frau R, Savoia P, Fanni S, Fiorentini C, Fidalgo C, Tronci E, Stancampiano R, Meloni M, Cannas A, Marrosu F, Bortolato M, Devoto P, Missale C, Carta M.
    Exp Neurol; 2017 May; 291():1-7. PubMed ID: 28131725
    [Abstract] [Full Text] [Related]

  • 12. Suppression of presynaptic corticostriatal glutamate activity attenuates L-dopa-induced dyskinesia in 6-OHDA-lesioned Parkinson's disease mice.
    Huang YT, Chen YW, Lin TY, Chen JC.
    Neurobiol Dis; 2024 Apr; 193():106452. PubMed ID: 38401650
    [Abstract] [Full Text] [Related]

  • 13. Levodopa/benserazide microsphere (LBM) prevents L-dopa induced dyskinesia by inactivation of the DR1/PKA/P-tau pathway in 6-OHDA-lesioned Parkinson's rats.
    Xie CL, Wang WW, Zhang SF, Yuan ML, Che JY, Gan J, Song L, Yuan WE, Liu ZG.
    Sci Rep; 2014 Dec 16; 4():7506. PubMed ID: 25511986
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The NK1 receptor antagonist N-acetyl-L-tryptophan reduces dyskinesia in a hemi-parkinsonian rodent model.
    Thornton E, Hassall MM, Corrigan F, Vink R.
    Parkinsonism Relat Disord; 2014 May 16; 20(5):508-13. PubMed ID: 24637127
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Intranigral administration of substance P receptor antagonist attenuated levodopa-induced dyskinesia in a rat model of Parkinson's disease.
    Yang X, Zhao H, Shi H, Wang X, Zhang S, Zhang Z, Zu J, Zhang W, Shen X, Cui G, Hua F.
    Exp Neurol; 2015 Sep 16; 271():168-74. PubMed ID: 26001615
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.